Evidence map›Paper›PMID 38928809›Full record

ArticleFoods (Basel, Switzerland)2024

Boosting Synergistic Antioxidant and Anti-Inflammatory Properties Blending Cereal-Based Nutraceuticals Produced Using Sprouting and Hydrolysis Tools.

Iván Jesús Jiménez-Pulido, Ana Belén Martín-Diana, Irene Tomé-Sánchez, Daniel de Luis, Cristina Martínez-Villaluenga, Daniel Rico

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iván Jesús Jiménez-PulidoAgrarian Technological Institute of Castilla and Leon (ITACyL), Ctra. Burgos Km 119, Finca Zamadueñas, 47071 Valladolid, Spain.ORCID 0000-0001-7095-9450
Ana Belén Martín-DianaAgrarian Technological Institute of Castilla and Leon (ITACyL), Ctra. Burgos Km 119, Finca Zamadueñas, 47071 Valladolid, Spain.ORCID 0000-0001-5014-9848
Irene Tomé-SánchezDepartment of Technological Processes and Biotechnology (DPTB), Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), 28040 Madrid, Spain.ORCID 0000-0001-6996-6645
Daniel de LuisEndocrinology and Clinical Nutrition Research Center (IENVA), Faculty of Medicine, University of Valladolid, Av. Ramón y Cajal, 3, 47003 Valladolid, Spain.ORCID 0000-0002-1745-9315
Cristina Martínez-VillaluengaDepartment of Technological Processes and Biotechnology (DPTB), Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), 28040 Madrid, Spain.ORCID 0000-0002-1155-6464
Daniel RicoEndocrinology and Clinical Nutrition Research Center (IENVA), Faculty of Medicine, University of Valladolid, Av. Ramón y Cajal, 3, 47003 Valladolid, Spain.ORCID 0000-0002-0755-3033

Funding

AEI/Spain and ESF/UE. PRE2019-087824
6 · The paper itself

Abstract

Nutraceuticals obtained from sprouted wheat and oat grains and processing by-products (bran and hull, respectively) naturally containing antioxidant and anti-inflammatory compounds were evaluated. The objective of this study was the development of a cereal-based nutraceutical formula combining extracts from sprouts and by-products and the exploration for potential synergetic effects in their bioactive properties. The antioxidant and anti-inflammatory capacities, glycemic index, phytic acid, and β-glucan of individual wheat bran hydrolysate (EH-WB), sprouted wheat (SW), oat hull hydrolysate (EH-OH), sprouted oat (SO), and combined ingredients (CI 1, CI 2, and CI3) were used to tailor an optimal nutraceutical formula. The three blend ingredients (CI 1, CI2, and CI3) were formulated at different ratios (EH-WB:SW:EH-OH:SO; 1:1:1:1, 2:1:2:1, and 1:2:1:2,

Indexed as

anti-inflammatoryantioxidanthydrolysisoatphytic acidsproutingwheatβ-glucans

Identifiers

PMID38928809
PMCPMC11203053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.